These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 23579162

  • 1. A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital.
    Taylor T, Bryant C, Popat S.
    Br Dent J; 2013 Apr; 214(7):E18. PubMed ID: 23579162
    [Abstract] [Full Text] [Related]

  • 2. Summary of: a study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital.
    Malden N.
    Br Dent J; 2013 Apr; 214(7):350-1. PubMed ID: 23579137
    [Abstract] [Full Text] [Related]

  • 3. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
    Lazarovici TS, Mesilaty-Gross S, Vered I, Pariente C, Kanety H, Givol N, Yahalom R, Taicher S, Yarom N.
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
    [Abstract] [Full Text] [Related]

  • 4. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.
    Urade M, Tanaka N, Furusawa K, Shimada J, Shibata T, Kirita T, Yamamoto T, Ikebe T, Kitagawa Y, Fukuta J.
    J Oral Maxillofac Surg; 2011 Nov; 69(11):e364-71. PubMed ID: 21782307
    [Abstract] [Full Text] [Related]

  • 5. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
    Otto S, Tröltzsch M, Jambrovic V, Panya S, Probst F, Ristow O, Ehrenfeld M, Pautke C.
    J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
    [Abstract] [Full Text] [Related]

  • 6. Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate.
    Ulmner M, Jarnbring F, Törring O.
    J Oral Maxillofac Surg; 2014 Jan; 72(1):76-82. PubMed ID: 23992777
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [Abstract] [Full Text] [Related]

  • 9. Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.
    Utreja A, Almas K, Javed F.
    Odontostomatol Trop; 2013 Jun; 36(142):38-46. PubMed ID: 24073539
    [Abstract] [Full Text] [Related]

  • 10. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER, Basile JD.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates.
    Shintani T, Hayashido Y, Mukasa H, Akagi E, Hoshino M, Ishida Y, Hamana T, Okamoto K, Kanda T, Koizumi K, Yoshioka Y, Tani R, Toratani S, Okamoto T.
    Int J Oral Maxillofac Surg; 2015 Jul; 44(7):840-4. PubMed ID: 25861974
    [Abstract] [Full Text] [Related]

  • 12. Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws.
    Holzinger D, Seemann R, Matoni N, Ewers R, Millesi W, Wutzl A.
    J Oral Maxillofac Surg; 2014 Oct; 72(10):1937.e1-8. PubMed ID: 25234534
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
    Dodson TB.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT, Smeets R, Riecke B, Weise E, Gröbe A, Blessmann M, Steiner T, Wikner J, Friedrich RE, Heiland M, Hoelzle F, Gerhards F.
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [Abstract] [Full Text] [Related]

  • 18. Dental extractions in patient treated with intravenous bisphosphonates and risk of osteonecrosis of jaws: presentation of a preventive protocol and case series.
    Ferlito S, Liardo C, Puzzo S.
    Minerva Stomatol; 2010 Sep; 59(11-12):593-601. PubMed ID: 21217623
    [Abstract] [Full Text] [Related]

  • 19. A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates.
    Thumbigere-Math V, Tu L, Huckabay S, Dudek AZ, Lunos S, Basi DL, Hughes PJ, Leach JW, Swenson KK, Gopalakrishnan R.
    Am J Clin Oncol; 2012 Aug; 35(4):386-92. PubMed ID: 22561331
    [Abstract] [Full Text] [Related]

  • 20. The observational study of delayed wound healing after tooth extraction in patients receiving oral bisphosphonate therapy.
    Hasegawa T, Ri S, Umeda M, Komatsubara H, Kobayashi M, Shigeta T, Yoshitomi I, Ikeda H, Shibuya Y, Asahina I, Komori T.
    J Craniomaxillofac Surg; 2013 Oct; 41(7):558-63. PubMed ID: 23332469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.